Home » Topics » Diagnostics, BioWorld Science

Diagnostics, BioWorld Science
RSS

99mTc-Labeled rituximab allows imaging of CD-20-expressing melanoma

Oct. 28, 2021

JMV-7488, a new 68Ga-radiolabeled peptide analogue for cancer imaging

Oct. 28, 2021

[18F]-TFB radiotracer useful for PET imaging of glioblastoma

Oct. 6, 2021

Assessing pharmacologic activity of PD(L)-1 MAb therapeutics in tumors by target pharmacodynamics

Sep. 29, 2021

OncoNano expands research collaboration with UTSW on novel cancer therapeutics

Sep. 23, 2021

NIH develops PET radioligands targeting CSF-1R for neuroinflammation

Sep. 9, 2021

[44Sc]Sc-B28110 shows preclinical promise as a radiotracer for the imaging of prostate cancer

Sep. 8, 2021

[11C]PDE7-136 as new PET neuroimaging candidate

Sep. 6, 2021

Scientists discover and characterize a selective hCYP11B2 PET tracer for primary hyperaldosteronism

Aug. 31, 2021

Phase I trial evaluates [11C]YJH-08 PET imaging of GR expression in metastatic prostate cancer

Aug. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.